Chris Mason

Chris Mason is a world-renowned expert in the field of cell and gene therapy. Chris has over 25 years of experience in the biotech industry, and has played a pivotal role in the development of many groundbreaking therapies. Chris is currently the Co-Founder & Non-Executive Director of Ori Biotech, a leading regenerative medicine company. Chris also serves on the boards of several other organizations, including the British Neurological Research Trust, the BioIndustry Association, and the UK Stem Cell Foundation. Chris is a Professor of Cell & Gene Therapy at University College London, and is the founder and CEO of the London Regenerative Medicine Network.

Chris Mason has a PhD in Medical Research from the University of London, and an Enterprise Fellowship from the Centre for Scientific Enterprise. Chris also has a Bachelor of Medicine, Bachelor of Surgery from King's College London, and a Bachelor of Science in Clinical Sciences from Imperial College London. In addition, they are certified by the Academy of Medical Sciences, the Royal College of Surgeons of England, the Royal College of Surgeons in Ireland, the Royal Society of Biology, and the General Medical Council.